Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 322
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01005160 | Drug Interaction Between CKD-501 and Metformin | ||
| NCT03583905 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet | ||
| NCT05931224 | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy | ||
| NCT04521023 | A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy | ||
| NCT05189288 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects | ||
| NCT06430047 | Efficacy and Safety of EsoDuo® | ||
| NCT03051841 | CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma | ||
| NCT01128322 | CKD-828 Primary Hypertension Trial(Dose-selection) | ||
| NCT01895894 | Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome | ||
| NCT03076957 | A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj. | ||
| NCT05552495 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions | ||
| NCT04627207 | A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers | ||
| NCT04069065 | Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL) | ||
| NCT04867200 | A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers | ||
| NCT02916901 | Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult Volunteers | ||
| NCT01682564 | To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure | ||
| NCT05108038 | A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects | ||
| NCT01270984 | Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects | ||
| NCT04906785 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions | ||
| NCT05347576 | A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions | ||
| NCT03067415 | Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily | ||
| NCT04102943 | Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients. | ||
| NCT01746680 | Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis | ||
| NCT02007941 | Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects | ||
| NCT01766505 | The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR) | ||
| NCT05741437 | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378 | ||
| NCT04548427 | Study to Evaluate the Efficacy and Safety of CKD-352 | ||
| NCT07304687 | Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers | ||
| NCT02300467 | NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors | ||
| NCT04867720 | Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients | ||
| NCT02526875 | Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled | ||
| NCT03067194 | The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients | ||
| NCT05749861 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5) | ||
| NCT01842256 | Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. | ||
| NCT04083846 | Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) | ||
| NCT01352689 | CKD-828(80/2.5mg) Pharmacokinetic Study_2nd | ||
| NCT03762369 | A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 | ||
| NCT03849261 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults | ||
| NCT04083872 | Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) | ||
| NCT03770052 | Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie | ||
| NCT03444402 | A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects | ||
| NCT03713892 | CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects | ||
| NCT04304547 | Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers | ||
| NCT02044250 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM) | ||
| NCT03858725 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers | ||
| NCT05238948 | CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects | ||
| NCT04651881 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions | ||
| NCT05897216 | Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029 | ||
| NCT03646799 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults | ||
| NCT05704621 | Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance |
